🔎 Trials Near Me

Hem › Interstitiella lungsjukdomar › New York

Kliniska studier för Interstitiella lungsjukdomar i New York

20 studier för Interstitiella lungsjukdomar söker deltagare vid platser i New York.

Städer i New York

Officiell studietext (engelska)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Weill Cornell Medicine-New York-60569, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Weill Cornell Medicine-New York-60569, New York
RekryterarFas 3
Ålder 40 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Weill Cornell Medicine, New York
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 29 sep. 2026 · NCT05798923

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07323732

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Icahn School of Medicine at Mount Sinai, New York
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Buffalo, Buffalo
  • Weill Cornell University Medical College, New York
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • NYU Langone Health, New York
  • University of Rochester Medical Center, Rochester
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Northwell Health, New Hyde Park
  • New York University Langone Medical Center, New York
  • New York Presbyterian Hospital - Weill Cornell Medicine, New York
  • och 1 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06388421

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  • Weill Cornell Medicine, New York
RekryterarObservationsstudie
Ålder 18 till 80 · Alla kön · Uppdaterad 18 aug. 2026 · NCT06855329

Platform Clinical Study for Conquering Scleroderma

  • Northwell Health, Great Neck
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Columbia University Irving Medical Center, New York
  • University of Rochester, Rochester
RekryterarFas 2/3
Ålder 18 till 75 · Alla kön · Uppdaterad 17 aug. 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Weill Medical College of Cornell University, New York
RekryterarObservationsstudie
Ålder 21 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT01915511

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

  • University of Rochester Medical Center, Rochester
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT07561034

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Northwell Health, New Hyde Park
  • Weill Cornell Medicine, New York-Presbyterian Hospital, New York
  • Stony Brook Advanced Specialty Care, Stony Brook
  • och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT05943535

Cough Capture as a Portal Into the Lung

  • Albert Einstein College of Medicine, The Bronx
RekryterarObservationsstudie
Ålder 21 och äldre · Alla kön · Uppdaterad 13 jan. 2026 · NCT05854563

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, New York
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 maj 2025 · NCT05892614

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.